UPMC CancerCenter is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
UPMC CancerCenter has participated in 2 clinical trials.
Therapeutic areas: Hematological Malignancies, Non-Hodgkin's Lymphoma (disorder), Acute Lymphoid Leukemia, Disease (disorder).
Sponsors: Kangpu Biopharmaceuticals, Ltd., Chimagen Biosciences, Ltd.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UPMC CancerCenter has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UPMC CancerCenter has 2 clinical trials on record. Their work covers Hematological Malignancies, Non-Hodgkin's Lymphoma (disorder), Acute Lymphoid Leukemia, Disease (disorder).
UPMC CancerCenter has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.